{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:04:03Z","timestamp":1790841843093,"version":"4.1.0"},"reference-count":177,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T00:00:00Z","timestamp":1600992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["2016-05073"],"award-info":[{"award-number":["2016-05073"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The plasminogen system is a critical proteolytic system responsible for the remodeling of the extracellular matrix (ECM). The master regulator of the plasminogen system, plasminogen activator inhibitor-1 (PAI-1), has been implicated for its role in exacerbating various disease states not only through the accumulation of ECM (i.e., fibrosis) but also its role in altering cell fate\/behaviour. Examination of PAI-1 has extended through various tissues and cell-types with recent investigations showing its presence in skeletal muscle. In skeletal muscle, the role of this protein has been implicated throughout the regeneration process, and in skeletal muscle pathologies (muscular dystrophy, diabetes, and aging-driven pathology). Needless to say, the complete function of this protein in skeletal muscle has yet to be fully elucidated. Given the importance of skeletal muscle in maintaining overall health and quality of life, it is critical to understand the alterations\u2014particularly in PAI-1\u2014that occur to negatively impact this organ. Thus, we provide a comprehensive review of the importance of PAI-1 in skeletal muscle health and function. We aim to shed light on the relevance of this protein in skeletal muscle and propose potential therapeutic approaches to aid in the maintenance of skeletal muscle health.<\/jats:p>","DOI":"10.3390\/ijms21197066","type":"journal-article","created":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T22:24:42Z","timestamp":1601245482000},"page":"7066","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["PAI-1, the Plasminogen System, and Skeletal Muscle"],"prefix":"10.3390","volume":"21","author":[{"given":"Fasih Ahmad","family":"Rahman","sequence":"first","affiliation":[{"name":"Department of Kinesiology, University of Waterloo, Waterloo, ON N2L 3G5, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew Paul","family":"Krause","sequence":"additional","affiliation":[{"name":"Department of Kinesiology, University of Windsor, Windsor, ON N9B 3P4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,9,25]]},"reference":[{"key":"ref_1","first-page":"661","article-title":"Fibrinolyse dans le sang","volume":"5","author":"Dastre","year":"1893","journal-title":"Arch. Physiol. Norm. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0140-6736(46)91017-3","article-title":"Observations on fibrinolysis plasminogen, plasmin, and antiplasmin content of human blood","volume":"248","author":"Macfarlane","year":"1946","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1085\/jgp.30.2.149","article-title":"The activation of plasminogen by chloroform","volume":"30","author":"Christensen","year":"1946","journal-title":"J. Gen. Physiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3181\/00379727-74-18063","article-title":"Plasminogen purification by acid extraction","volume":"74","author":"Christensen","year":"1950","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1172\/JCI102337","article-title":"Studies on a proteolytic enzyme system of the blood. II. fibrinolysokinase activators for profibrinolysin","volume":"29","author":"Lewis","year":"1950","journal-title":"J. Clin. Investig."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.100.2592.198","article-title":"Inhibition of \u03b2 hemolytic streptococci fibrinolysin by trypsin inhibitor","volume":"100","author":"Kaplan","year":"1944","journal-title":"Science"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1126\/science.101.2614.120","article-title":"A quantitative study of the fibrinolysin\u2014Antifibrinolysin reaction","volume":"101","author":"Kaplan","year":"1945","journal-title":"Science"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1073\/pnas.80.10.2956","article-title":"Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells","volume":"80","author":"Loskutoff","year":"1983","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1172\/JCI112761","article-title":"cDNA cloning of human plasminogen activator-inhibitor from endothelial cells","volume":"78","author":"Ginsburg","year":"1986","journal-title":"J. Clin. Investig."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1160\/TH08-07-0427","article-title":"Plasminogen activator inhibitor-1: The double-edged sword in apoptosis","volume":"100","author":"Balsara","year":"2008","journal-title":"Thromb. Haemost."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1160\/TH08-04-0266","article-title":"Regulation of programmed cell death by plasminogen activator inhibitor type 1 (PAI-1)","volume":"100","author":"Lademann","year":"2008","journal-title":"Thromb. Haemost."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1161\/ATVBAHA.117.309451","article-title":"Plasminogen activator inhibitor-1 is a marker and a mediator of senescence","volume":"37","author":"Vaughan","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Samarakoon, R., Higgins, S.P., Higgins, C.E., and Higgins, P.J. (2019). The TGF-\u03b21\/p53\/PAI-1 signaling axis in vascular senescence: Role of caveolin-1. Biomolecules, 9.","DOI":"10.3390\/biom9080341"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.2741\/2285","article-title":"Plasminogen activator inhibitor (PAI)-1 in vascular inflammation and thrombosis","volume":"12","author":"Aso","year":"2007","journal-title":"Front. Biosci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1182\/blood-2013-05-427708","article-title":"Inflammation, obesity, and thrombosis","volume":"122","author":"Samad","year":"2013","journal-title":"Blood"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1158\/0008-5472.CAN-15-0876","article-title":"Plasminogen activator inhibitor-1 in cancer: Rationale and insight for future therapeutic testing","volume":"75","author":"Placencio","year":"2015","journal-title":"Cancer Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/15384047.2014.1001271","article-title":"Inhibition of plasminogen activator inhibitor-1 is a potential therapeutic strategy in ovarian cancer","volume":"16","author":"Mashiko","year":"2015","journal-title":"Cancer Biol. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.biopha.2018.05.119","article-title":"Plasminogen activator inhibitor-1 in cancer research","volume":"105","author":"Li","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.canlet.2018.10.027","article-title":"PAI-1 secreted from metastatic ovarian cancer cells triggers the tumor-promoting role of the mesothelium in a feedback loop to accelerate peritoneal dissemination","volume":"442","author":"Peng","year":"2019","journal-title":"Cancer Lett."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.2174\/1381612033454621","article-title":"Plasminogen activator inhibitor-1 in tumor growth, angiogenesis and vascular remodeling","volume":"9","author":"Stefansson","year":"2003","journal-title":"Curr. Pharm. Des."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1111\/j.1538-7836.2005.01420.x","article-title":"PAI-1 and atherothrombosis","volume":"3","author":"Vaughan","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1161\/ATVBAHA.119.313775","article-title":"Drug targeting of plasminogen activator inhibitor-1 inhibits metabolic dysfunction and atherosclerosis in a murine model of metabolic syndrome","volume":"40","author":"Khoukaz","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"62S","DOI":"10.1016\/j.amjmed.2003.08.014","article-title":"Effect of plasminogen activator inhibitor-1 in diabetes mellitus and cardiovascular disease","volume":"115","author":"Lyon","year":"2003","journal-title":"Am. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"17714","DOI":"10.1038\/srep17714","article-title":"Plasminogen activator inhibitor-1 and type 2 diabetes: A systematic review and meta-analysis of observational studies","volume":"6","author":"Yarmolinsky","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.2741\/3361","article-title":"PAI-1 and kidney fibrosis","volume":"14","author":"Ma","year":"2009","journal-title":"Front. Biosci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2174\/138945007781662373","article-title":"PAI-1 as a target in kidney disease","volume":"8","author":"Huang","year":"2007","journal-title":"Curr. Drug Targets"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2337\/db11-0007","article-title":"Inhibition of plasminogen activator inhibitor-1 restores skeletal muscle regeneration in untreated type 1 diabetic mice","volume":"60","author":"Krause","year":"2011","journal-title":"Diabetes"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"C217","DOI":"10.1152\/ajpcell.00555.2004","article-title":"Mice deficient in plasminogen activator inhibitor-1 have improved skeletal muscle regeneration","volume":"289","author":"Koh","year":"2005","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Rahman, F.A., Angus, S.A., Stokes, K., Karpowicz, P., and Krause, M.P. (2020). Impaired ECM remodeling and macrophage activity define necrosis and regeneration following damage in aged skeletal muscle. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21134575"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2353\/ajpath.2009.081009","article-title":"Plasminogen activator inhibitor type 1 up-regulation is associated with skeletal muscle atrophy and associated fibrosis","volume":"175","author":"Naderi","year":"2009","journal-title":"Am. J. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1055\/s-0036-1586228","article-title":"The role of plasminogen activator inhibitor type-1 in fibrosis","volume":"43","author":"Flevaris","year":"2017","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jcp.22783","article-title":"PAI-1 in tissue fibrosis","volume":"227","author":"Ghosh","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1111\/j.1755-5922.2010.00171.x","article-title":"Plasminogen activator inhibitor-1 (pai-1): A key factor linking fibrinolysis and age-related subclinical and clinical conditions","volume":"28","author":"Cesari","year":"2010","journal-title":"Cardiovasc. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1083\/jcb.201105013","article-title":"PAI-1\u2013regulated miR-21 defines a novel age-associated fibrogenic pathway in muscular dystrophy","volume":"196","author":"Ardite","year":"2012","journal-title":"J. Cell Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1083\/jcb.200705127","article-title":"uPA deficiency exacerbates muscular dystrophy in MDX mice","volume":"178","author":"Suelves","year":"2007","journal-title":"J. Cell Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.2741\/1754","article-title":"The plasminogen activation system in skeletal muscle regeneration: Antagonistic roles of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1)","volume":"10","author":"Suelves","year":"2005","journal-title":"Front. Biosci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1182\/blood.V99.8.2835","article-title":"Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo","volume":"99","author":"Suelves","year":"2002","journal-title":"Blood"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood.V97.6.1703","article-title":"Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo","volume":"97","author":"Roma","year":"2001","journal-title":"Blood"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/labinvest.3780209","article-title":"Cell invasion is affected by differential expression of the urokinase plasminogen activator\/urokinase plasminogen activator receptor system in muscle satellite cells from normal and dystrophic patients","volume":"81","author":"Fibbi","year":"2001","journal-title":"Lab. Investig."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1055\/s-0038-1656001","article-title":"Inhibition of urokinase-type plasminogen activator (uPA) abrogates myogenesis in vitro","volume":"77","author":"Miralles","year":"1997","journal-title":"Thromb. Haemost."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1083\/jcb.201402079","article-title":"Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophy","volume":"207","author":"Dadgar","year":"2014","journal-title":"J. Cell Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"30091","DOI":"10.1074\/jbc.M202668200","article-title":"Slug is a novel downstream target of MyoD. Temporal profiling in muscle regeneration","volume":"277","author":"Zhao","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1758-5996-2-7","article-title":"Sedentary subjects have higher PAI-1 and lipoproteins levels than highly trained athletes","volume":"2","author":"Lira","year":"2010","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1152\/jappl.1976.40.3.287","article-title":"Fibrinolytic and hemostatic changes during and after maximal exercise in males","volume":"40","author":"Davis","year":"1976","journal-title":"J. Appl. Physiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s004210050415","article-title":"Fibrinolytic activity is not dependent upon exercise mode in post-myocardial infarction patients","volume":"78","author":"Fernhall","year":"1998","journal-title":"Eur. J. Appl. Physiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1440-2440(00)80005-5","article-title":"Changes in blood coagulation and fibrinolysis associated with maximal exercise and physical conditioning in women taking low dose oral contraceptives","volume":"3","author":"Hilberg","year":"2000","journal-title":"J. Sci. Med. Sport"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/BF00705040","article-title":"Effect of prolonged physical exercise on the fibrinolytic system","volume":"60","author":"Taenzer","year":"1990","journal-title":"Eur. J. Appl. Physiol. Occup. Physiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1152\/jappl.1986.60.3.986","article-title":"Physiological changes in hemostasis associated with acute exercise","volume":"60","author":"Wheeler","year":"1986","journal-title":"J. Appl. Physiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/0002-9149(92)90359-7","article-title":"Effects on platelet aggregation and fibrinolytic activity during upright posture and exercise in healthy men","volume":"70","author":"Winther","year":"1992","journal-title":"Am. J. Cardiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0002-8703(90)90198-7","article-title":"Clinical significance of plasminogen activator inhibitor activity in patients with exercise-induced ischemia","volume":"120","author":"Sakata","year":"1990","journal-title":"Am. Heart J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1249\/01.MSS.0000048634.89370.06","article-title":"A single bout of walking exercise enhances endogenous fibrinolysis in stroke patients","volume":"35","author":"Ivey","year":"2003","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/00005768-200102000-00007","article-title":"Fibrinolytic response to acute exercise in patients with peripheral arterial disease","volume":"33","author":"Womack","year":"2001","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/01.ATV.16.3.381","article-title":"Plasminogen activator inhibitor\u20131, tissue-type plasminogen activator, and fibrinogen","volume":"16","author":"Svendsen","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1055\/s-0030-1249623","article-title":"The influence of acute resistance training and body composition on coagulation and fibrinolytic activity in low-risk women","volume":"31","author":"Nagelkirk","year":"2010","journal-title":"Int. J. Sports Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1016\/j.thromres.2013.02.014","article-title":"Beneficial effects of habitual resistance exercise training on coagulation and fibrinolytic responses","volume":"131","author":"Kupchak","year":"2013","journal-title":"Thromb. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"559","DOI":"10.12965\/jer.1632788.394","article-title":"Moderate rest intervals are superior to short intervals for improving PAI-1 following exhaustive exercise in recreational weightlifters","volume":"12","author":"Rossi","year":"2016","journal-title":"J. Exerc. Rehabil."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1249\/00005768-199409000-00006","article-title":"Effects of exercise intensity, duration, and time of day on fibrinolytic activity in physically active men","volume":"26","author":"Szymanski","year":"1994","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1249\/01.MSS.0000145447.61736.ED","article-title":"Temporal changes in tPA and PAI-1 after maximal exercise","volume":"36","author":"Cooper","year":"2004","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood.V69.6.1600.1600","article-title":"Plasminogen activator in normal subjects after exercise and venous occlusion: T-PA circulates as complexes with C1-inhibitor and PAI-1","volume":"69","author":"Booth","year":"1987","journal-title":"Blood"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1055\/s-0038-1657639","article-title":"Effect of strenuous exercise on fibrinogen and fibrinolysis in healthy elderly men and women","volume":"78","author":"Schuit","year":"1997","journal-title":"Thromb. Haemost."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1055\/s-0038-1656086","article-title":"The fab-fragment of a PAI-1 inhibiting antibody reduces thrombus size and restores blood flow in a rat model of arterial thrombosis","volume":"77","author":"Wahlund","year":"1997","journal-title":"Thromb. Haemost."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3233\/JAD-180241","article-title":"A small molecule inhibitor of plasminogen activator inhibitor-1 reduces brain amyloid-\u03b2 load and improves memory in an animal model of alzheimer\u2019s disease","volume":"64","author":"Akhter","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1124\/jpet.105.084129","article-title":"Evaluation of PAI-039 [{1-benzyl-5-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}(oxo)acetic acid], a novel plasminogen activator inhibitor-1 inhibitor, in a canine model of coronary artery thrombosis","volume":"314","author":"Hennan","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.exger.2014.11.018","article-title":"Plasminogen activator inhibitor 1, fibroblast apoptosis resistance, and aging-related susceptibility to lung fibrosis","volume":"61","author":"Huang","year":"2015","journal-title":"Exp. Gerontol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/jcbfm.2009.272","article-title":"A novel inhibitor of plasminogen activator inhibitor-1 provides antithrombotic benefits devoid of bleeding effect in nonhuman primates","volume":"30","author":"Izuhara","year":"2010","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"L328","DOI":"10.1152\/ajplung.00217.2015","article-title":"Therapeutic potential of an orally effective small molecule inhibitor of plasminogen activator inhibitor for asthma","volume":"310","author":"Liu","year":"2016","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"E260","DOI":"10.1152\/ajpendo.00387.2018","article-title":"Inhibition of PAI-1 attenuates perirenal fat inflammation and the associated nephropathy in high-fat diet-induced obese mice","volume":"316","author":"Liu","year":"2019","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.1182\/blood-2011-12-399659","article-title":"Inhibition of PAI-1 induces neutrophil-driven neoangiogenesis and promotes tissue regeneration via production of angiocrine factors in mice","volume":"119","author":"Tashiro","year":"2012","journal-title":"Blood"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1111\/j.1538-7836.2006.02244.x","article-title":"Effect of pharmacologic plasminogen activator inhibitor-1 inhibition on cell motility and tumor angiogenesis","volume":"4","author":"Leik","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"9288","DOI":"10.1074\/jbc.M611642200","article-title":"Mechanism of inactivation of plasminogen activator inhibitor-1 by a small molecule inhibitor","volume":"282","author":"Gorlatova","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2174\/138945007781662337","article-title":"Structure-function relationships of plasminogen activator inhibitor-1 and its potential as a therapeutic agent","volume":"8","author":"Cale","year":"2007","journal-title":"Curr. Drug Targets"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1529\/biophysj.104.053306","article-title":"The Conversion of Active to Latent Plasminogen Activator Inhibitor-1 Is an Energetically Silent Event","volume":"88","author":"Boudier","year":"2005","journal-title":"Biophys. J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"25309","DOI":"10.1074\/jbc.270.43.25309","article-title":"Serpin-protease complexes are trapped as stable acyl-enzyme intermediates","volume":"270","author":"Lawrence","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"29652","DOI":"10.1074\/jbc.270.50.29652","article-title":"The inhibition mechanism of serpins. Evidence that the mobile reactive center loop is cleaved in the native protease-inhibitor complex","volume":"270","author":"Wilczynska","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2741\/3312","article-title":"Biochemical properties of plasminogen activator inhibitor-1","volume":"14","author":"Dupont","year":"2009","journal-title":"Front. Biosci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1515\/BC.2002.125","article-title":"Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin (Vn): Mapping the binding sites on PAI-1 and Vn","volume":"383","author":"Schroeck","year":"2002","journal-title":"Biol. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1515\/BC.2002.003","article-title":"The molecular basis for anti-proteolytic and non-proteolytic functions of plasminogen activator inhibitor type-1: Roles of the reactive centre loop, the shutter region, the flexible joint region and the small serpin fragment","volume":"383","author":"Wind","year":"2002","journal-title":"Biol. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"5112","DOI":"10.1074\/jbc.272.8.5112","article-title":"The use of fluorescent probes to characterize conformational changes in the interaction between vitronectin and plasminogen activator inhibitor-1","volume":"272","author":"Gibson","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_79","first-page":"5","article-title":"The urokinase plasminogen activator receptor in the regulation of the actin cytoskeleton and cell motility","volume":"383","year":"2002","journal-title":"Biol. Chem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1055\/s-0037-1615547","article-title":"Structure and Function of the Urokinase Receptor","volume":"82","author":"Mondino","year":"1999","journal-title":"Thromb. Haemost."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1091\/mbc.12.10.2975","article-title":"Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1","volume":"12","author":"Wei","year":"2001","journal-title":"Mol. Biol. Cell"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1055\/s-0037-1616208","article-title":"Protease crosstalk with integrins: The urokinase receptor paradigm","volume":"86","author":"Chapman","year":"2001","journal-title":"Thromb. Haemost."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/383441a0","article-title":"The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin","volume":"383","author":"Stefansson","year":"1996","journal-title":"Nature"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"pe24","DOI":"10.1126\/stke.2003.189.pe24","article-title":"Old dogs and new tricks: Proteases, inhibitors, and cell migration","volume":"2003","author":"Stefansson","year":"2003","journal-title":"Sci. STKE"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"12716","DOI":"10.1074\/jbc.271.22.12716","article-title":"Structural and functional analysis of the plasminogen activator inhibitor-1 binding motif in the somatomedin B domain of vitronectin","volume":"271","author":"Deng","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/j.1460-2075.1990.tb08213.x","article-title":"Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1","volume":"9","author":"Cubellis","year":"1990","journal-title":"EMBO J."},{"key":"ref_87","first-page":"423","article-title":"Induction of apoptosis in vascular cells by plasminogen activator inhibitor-1 and high molecular weight kininogen correlates with their anti-adhesive properties","volume":"384","author":"Chavakis","year":"2003","journal-title":"Biol. Chem."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1021\/bi00178a022","article-title":"Engineering plasminogen activator inhibitor-1 mutants with increased functional stability","volume":"33","author":"Lawrence","year":"1994","journal-title":"Biochemistry"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1002\/j.1460-2075.1995.tb07299.x","article-title":"Molecular evolution of plasminogen activator inhibitor-1 functional stability","volume":"14","author":"Berkenpas","year":"1995","journal-title":"EMBO J."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1074\/jbc.M112.371732","article-title":"Characterization of a small molecule inhibitor of plasminogen activator inhibitor type 1 that accelerates the transition into the latent conformation","volume":"288","author":"Deinum","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0268-9499(97)80114-2","article-title":"Comparison of chromogenic substrates for tissue plasminogen activator and the effects on the stability of plasminogen activator inhibitor type-1","volume":"11","author":"Ehnebom","year":"1997","journal-title":"Fibrinolysis Proteolysis"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"11581","DOI":"10.1016\/S0021-9258(17)39071-3","article-title":"Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants","volume":"260","author":"Hekman","year":"1985","journal-title":"J. Biol. Chem."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1161\/01.RES.67.5.1281","article-title":"Studies of recombinant plasminogen activator inhibitor-1 in rabbits. Pharmacokinetics and evidence for reactivation of latent plasminogen activator inhibitor-1 in vivo","volume":"67","author":"Vaughan","year":"1990","journal-title":"Circ. Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"17128","DOI":"10.1016\/S0021-9258(18)41903-5","article-title":"Plasminogen activator inhibitor-1 binds to fibrin and inhibits tissue-type plasminogen activator-mediated fibrin dissolution","volume":"267","author":"Reilly","year":"1992","journal-title":"J. Biol. Chem."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/01.RES.78.1.44","article-title":"Regulation of Matrix Metalloproteinases and Plasminogen Activator Inhibitor-1 Synthesis by Plasminogen in Cultured Human Vascular Smooth Muscle Cells","volume":"78","author":"Lee","year":"1996","journal-title":"Circ. Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1046\/j.1523-1755.2000.00274.x","article-title":"TIMP-1 gene expression and PAI-1 antigen after unilateral ureteral obstruction in the adult male rat","volume":"58","author":"Duymelinck","year":"2000","journal-title":"Kidney Int."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"162","DOI":"10.5214\/ans.0972.7531.1118413","article-title":"Novel target for Spinal Cord Injury related neuropathic pain","volume":"18","author":"Ahmed","year":"2011","journal-title":"Ann. Neurosci."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Leivonen, S.-K., Lazaridis, K., Decock, J., Chantry, A., Edwards, D.R., and K\u00e4h\u00e4ri, V.-M. (2013). TGF-\u03b2-Elicited Induction of Tissue Inhibitor of Metalloproteinases (TIMP)-3 Expression in Fibroblasts Involves Complex Interplay between Smad3, p38\u03b1, and ERK1\/2. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0057474"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1042\/bj3240611","article-title":"Transcriptional activity of the human tissue inhibitor of metalloproteinases 1 (TIMP-1) gene in fibroblasts involves elements in the promoter, exon 1 and intron 1","volume":"324 Pt 2","author":"Clark","year":"1997","journal-title":"Biochem. J."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/jcp.20228","article-title":"TGF-beta-induced expression of tissue inhibitor of metalloproteinases-3 gene in chondrocytes is mediated by extracellular signal-regulated kinase pathway and Sp1 transcription factor","volume":"203","author":"Qureshi","year":"2005","journal-title":"J. Cell. Physiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"8460","DOI":"10.1021\/bi000290w","article-title":"Structures of active and latent PAI-1: A possible stabilizing role for chloride ions","volume":"39","author":"Stout","year":"2000","journal-title":"Biochemistry"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1110\/ps.036707.108","article-title":"High-resolution structure of the stable plasminogen activator inhibitor type-1 variant 14-1B in its proteinase-cleaved form: A new tool for detailed interaction studies and modeling","volume":"17","author":"Jensen","year":"2008","journal-title":"Protein Sci."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/10641960902822468","article-title":"Plasminogen activator inhibitor-1 and the circadian clock in metabolic disorders","volume":"31","author":"Oishi","year":"2009","journal-title":"Clin. Exp. Hypertens."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/j.1460-2075.1987.tb02365.x","article-title":"Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts","volume":"6","author":"Lund","year":"1987","journal-title":"EMBO J."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1016\/S0021-9258(18)69042-8","article-title":"Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-beta. Divergent responses in lung fibroblasts and carcinoma cells","volume":"263","author":"Raghow","year":"1988","journal-title":"J. Biol. Chem."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.toxicon.2017.02.017","article-title":"Pneumolysin induces cellular senescence by increasing ROS production and activation of MAPK\/NF-\u03baB signal pathway in glial cells","volume":"129","author":"Kwon","year":"2017","journal-title":"Toxicon"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.18632\/aging.101998","article-title":"TGF-\u03b2 mediates aortic smooth muscle cell senescence in Marfan syndrome","volume":"11","author":"You","year":"2019","journal-title":"Aging"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1074\/jbc.M112.431973","article-title":"mitochondrial reactive oxygen species regulate transforming growth factor-\u03b2 signaling","volume":"288","author":"Jain","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1165\/rcmb.2013-0519OC","article-title":"Mitochondrial-targeted antioxidant therapy decreases transforming growth factor-\u03b2\u2013mediated collagen production in a murine asthma model","volume":"52","author":"Jaffer","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.bbrc.2003.08.102","article-title":"Reactive oxygen species mediate TGF-beta1-induced plasminogen activator inhibitor-1 upregulation in mesangial cells","volume":"309","author":"Jiang","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Samarakoon, R., Chitnis, S.S., Higgins, S.P., Higgins, C.E., Krepinsky, J.C., and Higgins, P.J. (2011). Redox-Induced Src Kinase and Caveolin-1 Signaling in TGF-\u03b21-Initiated SMAD2\/3 Activation and PAI-1 Expression. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0022896"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellsig.2017.11.005","article-title":"TGF-\u03b21\/p53 signaling in renal fibrogenesis","volume":"43","author":"Higgins","year":"2018","journal-title":"Cell. Signal."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1096\/fj.06-6285com","article-title":"Molecular regulation of the PAI-1 gene by hypoxia: Contributions of Egr-1, HIF-1 \u03b1, and C\/EBP\u03b1","volume":"21","author":"Liao","year":"2007","journal-title":"FASEB J."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1161\/01.ATV.0000258979.92828.bc","article-title":"Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site","volume":"27","author":"Bonello","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1182\/blood.V99.6.2077","article-title":"Identification of a tightly regulated hypoxia-response element in the promoter of human plasminogen activator inhibitor-1","volume":"99","author":"Fink","year":"2002","journal-title":"Blood"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S0021-9258(17)35287-0","article-title":"Multiple transforming growth factor-beta-inducible elements regulate expression of the plasminogen activator inhibitor type-1 gene in Hep G2 cells","volume":"266","author":"Westerhausen","year":"1991","journal-title":"J. Biol. Chem."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1160\/TH08-07-0490","article-title":"Metabolic, hormonal and environmental regulation of plasminogen activator inhibitor-1 (PAI-1) expression: Lessons from the liver","volume":"100","author":"Dimova","year":"2008","journal-title":"Thromb. Haemost."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"C1391","DOI":"10.1152\/ajpcell.1999.276.6.C1391","article-title":"TNF-alpha and insulin, alone and synergistically, induce plasminogen activator inhibitor-1 expression in adipocytes","volume":"276","author":"Sakamoto","year":"1999","journal-title":"Am. J. Physiol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"18127","DOI":"10.1074\/jbc.M310438200","article-title":"Tumor necrosis factor alpha activates the human plasminogen activator inhibitor-1 gene through a distal nuclear factor kappaB site","volume":"279","author":"Hou","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1159\/000480006","article-title":"Adiponectin Inhibits TNF-\u03b1-Activated PAI-1 Expression Via the cAMP-PKA-AMPK-NF-\u03baB Axis in Human Umbilical Vein Endothelial Cells","volume":"42","author":"Chen","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.biocel.2012.11.010","article-title":"Interleukin-17 modulates myoblast cell migration by inhibiting urokinase type plasminogen activator expression through p38 mitogen-activated protein kinase","volume":"45","author":"Bugarski","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"10739","DOI":"10.1016\/S0021-9258(18)82047-6","article-title":"The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells","volume":"268","author":"Dawson","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s001250100618","article-title":"Stimulation in vivo of expression of intra-abdominal adipose tissue plasminogen activator inhibitor Type I by proinsulin","volume":"44","author":"Nordt","year":"2001","journal-title":"Diabetologia"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1210\/mend-3-1-185","article-title":"Glucocorticoid and cyclic nucleotide regulation of plasminogen activator and plasminogen activator-inhibitor gene expression in primary cultures of rat hepatocytes","volume":"3","author":"Heaton","year":"1989","journal-title":"Mol. Endocrinol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"R345","DOI":"10.1152\/ajpregu.00454.2004","article-title":"Inflammatory processes in muscle injury and repair","volume":"288","author":"Tidball","year":"2005","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"R1152","DOI":"10.1152\/ajpregu.00132.2007","article-title":"The urokinase-type plasminogen activator receptor is not required for skeletal muscle inflammation or regeneration","volume":"293","author":"Bryer","year":"2007","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.4049\/jimmunol.1004091","article-title":"Macrophage-specific expression of urokinase-type plasminogen activator promotes skeletal muscle regeneration","volume":"187","author":"Novak","year":"2011","journal-title":"J. Immunol."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Krause, M.P., Al-Sajee, D., D\u2019Souza, D.M., Rebalka, I.A., Moradi, J., Riddell, M.C., and Hawke, T.J. (2013). Impaired Macrophage and Satellite Cell Infiltration Occurs in a Muscle-Specific Fashion Following Injury in Diabetic Skeletal Muscle. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0070971"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1152\/jappl.2001.91.2.534","article-title":"Myogenic satellite cells: Physiology to molecular biology","volume":"91","author":"Hawke","year":"2001","journal-title":"J. Appl. Physiol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1242\/dev.114223","article-title":"Intrinsic and extrinsic mechanisms regulating satellite cell function","volume":"142","author":"Dumont","year":"2015","journal-title":"Development"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1365-2990.1998.00118.x","article-title":"Matrix metalloproteinases MMP-2 and MMP-9 in denervated muscle and injured nerve","volume":"24","author":"Kherif","year":"1998","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s00774-017-0825-8","article-title":"Role of plasminogen activator inhibitor-1 in glucocorticoid-induced muscle change in mice","volume":"36","author":"Tamura","year":"2018","journal-title":"J. Bone Miner. Metab."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/excr.2002.5642","article-title":"The urokinase plasminogen activator: An interesting way to improve myoblast migration following their transplantation","volume":"280","author":"Elfahime","year":"2002","journal-title":"Exp. Cell Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1006\/dbio.1998.9107","article-title":"Expression of matrix metalloproteinases 2 and 9 in regenerating skeletal muscle: A study in experimentally injured and mdx muscles","volume":"205","author":"Kherif","year":"1999","journal-title":"Dev. Biol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"C529","DOI":"10.1152\/ajpcell.00051.2013","article-title":"Matrix metalloproteinase 13 is a new contributor to skeletal muscle regeneration and critical for myoblast migration","volume":"305","author":"Lei","year":"2013","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1023\/A:1005670507906","article-title":"Gelatinase-B (Matrix Metalloproteinase-9; MMP-9) secretion is involved in the migratory phase of human and murine muscle cell cultures","volume":"21","author":"Lewis","year":"2000","journal-title":"J. Muscle Res. Cell Motil."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1387\/ijdb.072331mz","article-title":"Distinct patterns of MMP-9 and MMP-2 activity in slow and fast twitch skeletal muscle regeneration in vivo","volume":"52","author":"Zimowska","year":"2008","journal-title":"Int. J. Dev. Biol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/excr.2000.4962","article-title":"In Vivo Migration of Transplanted Myoblasts Requires Matrix Metalloproteinase Activity","volume":"258","author":"Elfahime","year":"2000","journal-title":"Exp. Cell Res."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/mus.20383","article-title":"Regulation of TIMP-2, MT1-MMP, and MMP-2 expression during C2C12 differentiation","volume":"32","author":"Lluri","year":"2005","journal-title":"Muscle Nerve"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1152\/japplphysiol.00670.2006","article-title":"Matrix metalloproteinase-1 therapy improves muscle healing","volume":"102","author":"Bedair","year":"2007","journal-title":"J. Appl. Physiol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.actbio.2008.03.010","article-title":"Matrix metalloproteinase-1 treatment of muscle fibrosis","volume":"4","author":"Kaar","year":"2008","journal-title":"Acta Biomater."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2353\/ajpath.2009.080509","article-title":"Matrix metalloproteinase-1 promotes muscle cell migration and differentiation","volume":"174","author":"Wang","year":"2009","journal-title":"Am. J. Pathol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"333","DOI":"10.33594\/000000223","article-title":"Matrix Metalloproteinase 13 from Satellite Cells is Required for Efficient Muscle Growth and Regeneration","volume":"54","author":"Smith","year":"2020","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1542\/peds.55.1.30","article-title":"Newborn screening for Duchenne muscular dystrophy","volume":"55","author":"Zellweger","year":"1975","journal-title":"Pediatrics"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1515\/BC.2002.013","article-title":"Growth factor-dependent proliferation and invasion of muscle satellite cells require the cell-associated fibrinolytic system","volume":"383","author":"Fibbi","year":"2002","journal-title":"Biol. Chem."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1399-5448.2010.00699.x","article-title":"Effects of type 1 diabetes mellitus on skeletal muscle: Clinical observations and physiological mechanisms","volume":"12","author":"Krause","year":"2011","journal-title":"Pediatr. Diabetes"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1152\/japplphysiol.91565.2008","article-title":"Diabetic myopathy differs between Ins2Akita+\/\u2212 and streptozotocin-induced Type 1 diabetic models","volume":"106","author":"Krause","year":"2009","journal-title":"J. Appl. Physiol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00125-018-4602-6","article-title":"Altered mitochondrial bioenergetics and ultrastructure in the skeletal muscle of young adults with type 1 diabetes","volume":"61","author":"Monaco","year":"2018","journal-title":"Diabetologia"},{"key":"ref_149","first-page":"4","article-title":"Diabetic myopathy: Impact of diabetes mellitus on skeletal muscle progenitor cells","volume":"4","author":"Hawke","year":"2013","journal-title":"Front. Physiol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1055\/s-2001-14837","article-title":"Prospective study on plasma clotting parameters in diabetic children\u2014No evidence for specific changes in coagulation system","volume":"109","author":"Zeitler","year":"2001","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1161\/ATVBAHA.107.160168","article-title":"Plasminogen Activator Inhibitor-1 Activity in Type 2 Diabetes","volume":"28","author":"Brazionis","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fphys.2017.01088","article-title":"Statin Therapy Negatively Impacts Skeletal Muscle Regeneration and Cutaneous Wound Repair in Type 1 Diabetic Mice","volume":"8","author":"Rebalka","year":"2017","journal-title":"Front. Physiol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The Hallmarks of Aging","volume":"153","author":"Blasco","year":"2013","journal-title":"Cell"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.cardiores.2004.11.013","article-title":"Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: Implication in the pathogenesis of thrombotic disorders in the elderly","volume":"66","author":"Yamamoto","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1055\/s-0034-1387883","article-title":"Role of plasminogen activator inhibitor-1 in senescence and aging","volume":"40","author":"Eren","year":"2014","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"e12953","DOI":"10.1111\/acel.12953","article-title":"Glycine supplementation extends lifespan of male and female mice","volume":"18","author":"Miller","year":"2019","journal-title":"Aging Cell"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1182\/blood.V77.3.528.528","article-title":"A lifelong bleeding disorder associated with a deficiency of plasminogen activator inhibitor type 1","volume":"77","author":"Nguyen","year":"1991","journal-title":"Blood"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1182\/blood.V90.1.204.204_204_208","article-title":"Human Plasminogen Activator Inhibitor-1 (PAI-1) Deficiency: Characterization of a Large Kindred with a Null Mutation in the PAI-1 Gene","volume":"90","author":"Fay","year":"1997","journal-title":"Blood"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"eaao1617","DOI":"10.1126\/sciadv.aao1617","article-title":"A null mutation in SERPINE1 protects against biological aging in humans","volume":"3","author":"Khan","year":"2017","journal-title":"Sci. Adv."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Akhmedov, D., and Berdeaux, R. (2013). The effects of obesity on skeletal muscle regeneration. Front. Physiol., 4.","DOI":"10.3389\/fphys.2013.00371"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2337\/db15-0647","article-title":"Obesity Impairs Skeletal Muscle Regeneration through Inhibition of AMPK","volume":"65","author":"Fu","year":"2016","journal-title":"Diabetes"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nm.3710","article-title":"Inducible depletion of satellite cells in adult, sedentary mice impairs muscle regenerative capacity without affecting sarcopenia","volume":"21","author":"Fry","year":"2015","journal-title":"Nat. Med."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"C467","DOI":"10.1152\/ajpcell.00355.2007","article-title":"Recovery of skeletal muscle mass after extensive injury: Positive effects of increased contractile activity","volume":"294","author":"Serrurier","year":"2008","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0026-0495(97)90066-4","article-title":"Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome","volume":"46","author":"Velazquez","year":"1997","journal-title":"Metabolism"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1172\/JCI116445","article-title":"Plasminogen activator inhibitor-1 synthesis in the human hepatoma cell line Hep G2. Metformin inhibits the stimulating effect of insulin","volume":"91","author":"Anfosso","year":"1993","journal-title":"J. Clin. Investig."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/cvr\/cvp131","article-title":"Metformin decreases angiogenesis via NF-\u03baB and Erk1\/2\/Erk5 pathways by increasing the antiangiogenic thrombospondin-1","volume":"83","author":"Tan","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Langone, F., Cannata, S., Fuoco, C., Lettieri Barbato, D., Testa, S., Nardozza, A.P., Ciriolo, M.R., Castagnoli, L., Gargioli, C., and Cesareni, G. (2014). Metformin Protects Skeletal Muscle from Cardiotoxin Induced Degeneration. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0114018"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"793525","DOI":"10.1155\/2013\/793525","article-title":"Resveratrol suppresses PAI-1 gene expression in a human in vitro model of inflamed adipose tissue","volume":"2013","author":"Zagotta","year":"2013","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.bbrc.2007.10.109","article-title":"Resveratrol inhibits TNF-alpha-induced changes of adipokines in 3T3-L1 adipocytes","volume":"364","author":"Ahn","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.febslet.2008.01.024","article-title":"A possible link between resveratrol and TGF-\u03b2: Resveratrol induction of TGF-\u03b2 expression and signaling","volume":"582","author":"Suenaga","year":"2008","journal-title":"FEBS Lett."},{"key":"ref_171","first-page":"189168","article-title":"Plasminogen activator inhibitor-1 regulates LPS induced inflammation in rat macrophages through autophagy activation","volume":"2014","author":"Wang","year":"2014","journal-title":"Sci. World J."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1002\/jcb.26384","article-title":"Curcumin alleviates IL-17A-mediated p53-PAI-1 expression in bleomycin-induced alveolar basal epithelial cells","volume":"119","author":"Gouda","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000287230","article-title":"Curcumin inhibits transforming growth factor-beta activity via inhibition of Smad signaling in HK-2 cells","volume":"31","author":"Hu","year":"2010","journal-title":"Am. J. Nephrol."},{"key":"ref_174","first-page":"125","article-title":"Efficiency of Ginkgo biloba extract (EGb 761) in antioxidant protection against myocardial ischemia and reperfusion injury","volume":"35","author":"Shen","year":"1995","journal-title":"Biochem. Mol. Biol. Int."},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Leiherer, A., Stoemmer, K., Muendlein, A., Saely, C.H., Kinz, E., Brandtner, E.M., Fraunberger, P., and Drexel, H. (2016). Quercetin Impacts Expression of Metabolism- and Obesity-Associated Genes in SGBS Adipocytes. Nutrients, 8.","DOI":"10.3390\/nu8050282"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1523-1755.2004.00713.x","article-title":"Curcumin blocks multiple sites of the TGF-beta signaling cascade in renal cells","volume":"66","author":"Gaedeke","year":"2004","journal-title":"Kidney Int."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.fitote.2016.07.010","article-title":"Modulation of plasminogen activator inhibitor-1 (PAI-1) by the naphthoquinone shikonin","volume":"113","author":"Han","year":"2016","journal-title":"Fitoterapia"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/19\/7066\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:13:51Z","timestamp":1760177631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/19\/7066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,25]]},"references-count":177,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2020,10]]}},"alternative-id":["ijms21197066"],"URL":"https:\/\/doi.org\/10.3390\/ijms21197066","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,25]]}}}